FXR agonist 3

1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

FXR agonist 3 is an anti-NASH agent, acting by activating FXR. FXR agonist 3 inhibits COL1A1, TGF-β1, α-SMA and TIMP1 expression with anti-fibrogenic activity. FXR agonist 3 significantly reduces liver steatosis and inflammation, improves liver fibrosis level.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 96.51%
  • CAS. Nr.: 3037847-72-3
  • Formel: C28H28BrNO4
  • Molecular Weight:522.43
  • Speicherung:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) FXR agonist 3

More
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00